Chalampalakis Zacharias, Ortner Markus, Almuttairi Masar, Bauer Martin, Tamm Ernesto Gomez, Schmidt Albrecht Ingo, Geist Barbara Katharina, Hacker Marcus, Langer Oliver, Frass-Kriegl Roberta, Rausch Ivo
QIMP Team, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Department of Pharmacy, Al-Manara College for Medical Sciences, Maysan, Iraq.
EJNMMI Phys. 2024 Nov 4;11(1):90. doi: 10.1186/s40658-024-00694-4.
Accurate pharmacokinetic modelling in PET necessitates measurements of an input function, which ideally is acquired non-invasively from image data. For hepatic pharmacokinetic modelling two input functions need to be considered, to account for the blood supply from the hepatic artery and portal vein. Image-derived measurements at the portal vein are challenging due to its small size and image artifacts caused by respiratory motion. In this work we seek to demonstrate, using phantom experiments, how a dedicated PET/MR protocol can tackle these challenges and potentially provide input function measurements of the portal vein in a clinical setup.
A custom 3D printed PET/MR phantom was constructed to mimic the liver and portal vein. PET/MR acquisitions were made with emulated respiratory motion. The PET/MR imaging protocol consisted of high-resolution anatomical MR imaging of the portal vein, followed by a PET acquisition in parallel to a dedicated motion-tracking MR sequence. Motion tracking and deformation information were extracted from PET data and subsequently used in PET reconstruction to produce dynamic series of motion-free PET images. Anatomical MR images were used post PET reconstruction for partial volume correction of the input function measurements.
Reconstruction of dynamic PET data with motion-compensation provided nearly motion-free series of PET frame data, suitable for image derived input function measurements of the portal vein. After partial volume correction, the individual input function measurements were within a 16.1% error range from the true activity in the portal vein compartment at the time of PET acquisition.
The proposed protocol demonstrates clinically feasible PET/MR imaging of the liver for pharmacokinetic studies with accurate quantification of the portal vein input function, including correction for respiratory motion and partial volume effects.
正电子发射断层扫描(PET)中准确的药代动力学建模需要测量输入函数,理想情况下该函数应从图像数据中无创获取。对于肝脏药代动力学建模,需要考虑两个输入函数,以说明肝动脉和门静脉的血液供应情况。由于门静脉尺寸较小且呼吸运动导致图像伪影,从图像中测量门静脉具有挑战性。在本研究中,我们试图通过体模实验证明,专用的PET/MR协议如何应对这些挑战,并有可能在临床环境中提供门静脉输入函数的测量值。
构建了一个定制的3D打印PET/MR体模,以模拟肝脏和门静脉。在模拟呼吸运动的情况下进行PET/MR采集。PET/MR成像协议包括门静脉的高分辨率解剖MR成像,随后是与专用运动跟踪MR序列并行的PET采集。从PET数据中提取运动跟踪和变形信息,并随后用于PET重建,以生成无运动的PET图像动态序列。PET重建后使用解剖MR图像对输入函数测量进行部分容积校正。
通过运动补偿重建动态PET数据,提供了几乎无运动的PET帧数据序列,适用于门静脉图像衍生输入函数测量。经过部分容积校正后,各个输入函数测量值与PET采集时门静脉区域的真实活性误差范围在16.1%以内。
所提出的协议证明了用于药代动力学研究的肝脏PET/MR成像在临床上是可行的,能够准确量化门静脉输入函数,包括对呼吸运动和部分容积效应的校正。